文献速递产科

Foley导管与口服米索前列醇引产比较:个体参与者数据荟萃分析

Foley catheter vs oral misoprostol for induction of labor: individual participant data meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该研究通过个体参与者数据荟萃分析比较Foley导管与口服米索前列醇引产的效果与安全性,纳入4项随机对照试验共2815名孕妇。结果显示Foley导管组阴道分娩率略低(RR 0.95,95%CI 0.91-0.99),围产期不良结局复合指标有降低趋势(RR 0.71,95%CI 0.48-1.05),但母亲不良结局复合指标无差异(RR 1.00,95%CI 0.97-1.03)。

要点

  • Foley导管引产的阴道分娩率略低于口服米索前列醇(RR 0.95)。
  • Foley导管组围产期不良结局复合指标有降低趋势,但差异无统计学意义。
  • 两组母亲不良结局复合指标无差异,安全性相当。

核心结论

  • 对于引产孕妇,Foley导管的引产效果不如口服米索前列醇,表现为阴道分娩率略低。
  • Foley导管引产可能降低围产期不良结局,但母亲安全性无显著差异。

研究设计与样本

  • 个体参与者数据荟萃分析,纳入4项随机对照试验共2815名引产孕妇,Foley导管组1399例,口服米索前列醇组1416例。
  • 检索数据库包括Cochrane综述、MEDLINE、EMBASE等,检索时间至2019年4月。
  • 采用两阶段随机效应模型,按意向性治疗原则分析,使用Cochrane RoB 2和GRADE评估质量。

主要发现

  • Foley导管组阴道分娩率略低于口服米索前列醇组(RR 0.95,95%CI 0.91-0.99;I2=2.0%;中等确定性证据)。
  • 围产期不良结局复合指标在Foley导管组有降低趋势(RR 0.71,95%CI 0.48-1.05;I2=14.9%;低确定性证据)。
  • 母亲不良结局复合指标两组无差异(RR 1.00,95%CI 0.97-1.03;I2=0%;中等确定性证据)。
  • 干预与产次或孕周之间无显著交互作用。

关键数值与推荐

  • 主要结局:阴道分娩、围产期不良结局复合指标(包括死产、新生儿死亡、新生儿惊厥、NICU入住、严重呼吸窘迫或胎粪吸入综合征)、母亲不良结局复合指标(包括ICU入住、母亲感染、严重产后出血、母亲死亡或子宫破裂)。

临床怎么用

  • 临床选择引产方法时,需权衡Foley导管可能降低围产期不良结局的趋势与其阴道分娩率略低的不足。
  • 对于关注围产期安全性的孕妇,可考虑Foley导管,但应告知其阴道分娩成功率可能略低于口服米索前列醇。

局限性

  • 仅纳入提供个体参与者数据的4项试验,可能存在选择偏倚。
  • 围产期不良结局的证据确定性为低,需更多研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the effectiveness and safety of Foley catheter and oral misoprostol for induction of labor (IOL). METHODS: The Cochrane Review on Mechanical Methods for Induction of Labour and Ovid MEDLINE, EMBASE via Ovid, Ovid Emcare, CINAHL Plus, ClinicalTrials.gov and Scopus, from inception to April 2019, were searched for randomized controlled trials (RCTs) comparing Foley catheter to oral misoprostol for IOL in viable singleton gestations. Eligible trials for which raw data were obtained were included and individual participant data meta-analysis was performed. Primary outcomes were vaginal birth, a composite of adverse perinatal outcome (including stillbirth, neonatal death, neonatal seizures, admission to the neonatal intensive care unit, severe respiratory compromise or meconium aspiration syndrome) and a composite of adverse maternal outcome (including admission to the intensive care unit, maternal infection, severe postpartum hemorrhage, maternal death or uterine rupture). The quality of the included RCTs was assessed using the Cochrane Risk of Bias 2 tool and the certainty of evidence was evaluated using the GRADE approach. A two-stage random-effects model was used for meta-analysis according to the intention-to-treat principle and interactions between treatment and baseline characteristics were assessed. RESULTS: Of seven eligible trials, four provided individual participant data for a total of 2815 participants undergoing IOL, of whom 1399 were assigned to Foley catheter and 1416 to oral misoprostol. All four trials provided data for each of the primary outcomes in all 2815 women. Compared with those receiving oral misoprostol, Foley catheter recipients had a slightly decreased chance of vaginal birth (risk ratio (RR), 0.95 (95% CI, 0.91-0.99); I2 , 2.0%; moderate-certainty evidence). A trend towards a lower rate of composite adverse perinatal outcome was found in women undergoing IOL using a Foley catheter compared with oral misoprostol (RR, 0.71 (95% CI, 0.48-1.05); I2 , 14.9%; low-certainty evidence). Composite adverse maternal outcome did not differ between the groups (RR, 1.00 (95% CI, 0.97-1.03); I2 , 0%; moderate-certainty evidence). Meta-analyses of effect modifications did not show significant interactions between intervention and parity or gestational age for any of the primary outcomes. CONCLUSIONS: For women undergoing IOL, Foley catheter is less effective than oral misoprostol, as it was associated with fewer vaginal births. However, while we found no significant difference in maternal safety, Foley catheter induction may reduce adverse perinatal outcomes. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kemper JI, Li W, Goni S, et al. Foley catheter vs oral misoprostol for induction of labor: individual participant data meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 33258514. doi:10.1002/uog.23563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。